Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21991949

Adjuvant trastuzumab in HER2-positive breast cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2011 Oct 6
First author
Slamon D

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2011 Oct 6;365(14):1336-8. doi: 10.1056/NEJMe1101326.
    note
    Source null
    related pmid
    21991956
    relationship
    Comment in
  2. citation
    N Engl J Med. 2012 Feb 16;366(7):663; author reply 664-6. doi: 10.1056/NEJMc1112823.
    note
    Source null
    related pmid
    22335747
    relationship
    Comment in
  3. citation
    N Engl J Med. 2012 Feb 16;366(7):663-4; author reply 664-6. doi: 10.1056/NEJMc1112823.
    note
    Source null
    related pmid
    22335748
    relationship
    Comment in
  4. citation
    N Engl J Med. 2012 Feb 16;366(7):664; author reply 664-6. doi: 10.1056/NEJMc1112823.
    note
    Source null
    related pmid
    22335749
    relationship
    Comment in
  5. citation
    N Engl J Med. 2012 Feb 16;366(7):664; author reply 664-6. doi: 10.1056/NEJMc1112823.
    note
    Source null
    related pmid
    22335750
    relationship
    Comment in

Authors and identifiers

  1. name
    Slamon D
    type
    Author
  2. name
    Eiermann W
    type
    Author
  3. name
    Robert N
    type
    Author
  4. name
    Pienkowski T
    type
    Author
  5. name
    Martin M
    type
    Author
  6. name
    Press M
    type
    Author
  7. name
    Mackey J
    type
    Author
  8. name
    Glaspy J
    type
    Author
  9. name
    Chan A
    type
    Author
  10. name
    Pawlicki M
    type
    Author
  11. name
    Pinter T
    type
    Author
  12. name
    Valero V
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Slamon D
    type
    Author
  2. name
    Eiermann W
    type
    Author
  3. name
    Robert N
    type
    Author
  4. name
    Pienkowski T
    type
    Author
  5. name
    Martin M
    type
    Author
  6. name
    Press M
    type
    Author
  7. name
    Mackey J
    type
    Author
  8. name
    Glaspy J
    type
    Author
  9. name
    Chan A
    type
    Author
  10. name
    Pawlicki M
    type
    Author
  11. name
    Pinter T
    type
    Author
  12. name
    Valero V
    type
    Author
bibliography ids
  1. nci-bib-e68a1b14ee59889496aac1b5
book metadata
content sha256
bc162a2a25401f52d6b6ae86cee1ff9d21eef2eadc9c29fd9a370aacc8e6310b
document type
citation
dois
  1. 10.1056/NEJMoa0910383
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:21991949
immutable id
pubmed:21991949@bc162a2a25401f52d6b6ae86cee1ff9d21eef2eadc9c29fd9a370aacc8e6310b
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
14
name
The New England journal of medicine
nlm unique id
0255562
pages
1273-83
volume
365
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2011 Oct 6;365(14):1336-8. doi: 10.1056/NEJMe1101326.
    note
    Source null
    related pmid
    21991956
    relationship
    Comment in
  2. citation
    N Engl J Med. 2012 Feb 16;366(7):663; author reply 664-6. doi: 10.1056/NEJMc1112823.
    note
    Source null
    related pmid
    22335747
    relationship
    Comment in
  3. citation
    N Engl J Med. 2012 Feb 16;366(7):663-4; author reply 664-6. doi: 10.1056/NEJMc1112823.
    note
    Source null
    related pmid
    22335748
    relationship
    Comment in
  4. citation
    N Engl J Med. 2012 Feb 16;366(7):664; author reply 664-6. doi: 10.1056/NEJMc1112823.
    note
    Source null
    related pmid
    22335749
    relationship
    Comment in
  5. citation
    N Engl J Med. 2012 Feb 16;366(7):664; author reply 664-6. doi: 10.1056/NEJMc1112823.
    note
    Source null
    related pmid
    22335750
    relationship
    Comment in
outcomes validated
false
pmid
21991949
provenance
batch id
2529ef2eca926738ab13
provider
NCBI PubMed ESummary
record sha256
d19dd4d82353f8a94469c31341924c240291ca0a2b56030e318ed0eeccc03891
response sha256
9204e3dd8d67df5a6773613a8059d8d42d9842ee24eecc9b0f39a62f636c99b6
retrieved at
2026-09-09T23:46:42.856296+00:00
publication date
display
2011 Oct 6
precision
day
year
2011
publication types
  1. Journal Article
  2. Multicenter Study
  3. Randomized Controlled Trial
  4. Research Support, N.I.H., Extramural
  5. Research Support, Non-U.S. Gov't
  6. Research Support, U.S. Gov't, Non-P.H.S.
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/21991949/
title
Adjuvant trastuzumab in HER2-positive breast cancer.

Preserved source evidence · Not medical advice